首页 | 官方网站   微博 | 高级检索  
     

具可放大性的红景天苷合成工艺研究(英文)
引用本文:梁清照,李辉,张文轩,孟祥豹,李中军.具可放大性的红景天苷合成工艺研究(英文)[J].中国药学,2014,23(7):446-453.
作者姓名:梁清照  李辉  张文轩  孟祥豹  李中军
作者单位:北京大学医学部天然药物及仿生药物国家重点实验室:药学院化学生物学系,北京100191
基金项目:the National Basic Research Program of China(973 Program,Grant No.2012CB822100);the National Key Technology R&D Program“New Drug Innovation”of China(Grant No.2012ZX09502001-001);the National Natural Science Foundation of China(Grant No.21232002,21072016 and 21072017)
摘    要:通过分析现有红景天苷化学合成方法的优缺点,分析制约现有工艺可放大性的关键因素,采用通过优化酪醇酚羟基酰基保护基的类型实现关键中间体结晶性的策略,探索发展出了具可放大性的红景天苷合成新工艺:以无水ZnCl2为催化剂,高活性、价廉易得的β-D-五乙酰葡萄糖为供体,苯甲酰基保护酚羟基酪醇为受体进行苷化反应,以MeONa/MeOH脱保护得到红景天苷。新工艺共三步反应,总收率47%;路线涉及的中间体均可通过重结晶进行纯化,革除了柱层析操作,显著降低了生产成本,具备可放大性。

关 键 词:红景天苷  苷元酰化保护  重结晶  可放大性  合成

Scalable synthesis of salidroside
Qingzhao Liang,Hui Li,Wenxuan Zhang,Xiangbao Meng,Zhongjun Li.Scalable synthesis of salidroside[J].Journal of Chinese Pharmaceutical Sciences,2014,23(7):446-453.
Authors:Qingzhao Liang  Hui Li  Wenxuan Zhang  Xiangbao Meng  Zhongjun Li
Affiliation:( State Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, School of Pharmaceutical Sciences Peking University Health Sciences Center, Beij ing 100191, China)
Abstract:By analyzing the key steps that restricted the industrial synthesis of salidroside, selective protection of tyrosol with different acylation reagents was adopted. The strategy facilitated the crystallization of intermediates, which allowed the scalable synthesis of salidroside. It included a reaction of penta-O-acetyl-β-D-glucose with acyl protected tyrosol in the presence of Lewis acid catalyst(ZnCl2), followed by deacylation under basic condition(NaOMe/MeOH) to give the salidroside. The total yield of this three-step reaction was 47%. Final product and intermediates were purified by recrystallization, which significantly reduced the cost and made the large scale synthesis feasible.
Keywords:Salidroside  Acylation of tyrosol  Crystallization  Scale up feasibility  Synthesis
本文献已被 维普 等数据库收录!
点击此处可从《中国药学》浏览原始摘要信息
点击此处可从《中国药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号